NCT02780024View on ClinicalTrials.gov

Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 20, 2021

Study Completion Date

February 28, 2027

Conditions
Glioblastoma Multiforme
Interventions
DRUG

Metformin

Metformin,

Trial Locations (1)

H3A 2B4

Montreal Neurological Institute - McGill University Health Centre, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER